文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

英国心血管介入学会院外心脏骤停转运算法的成本-效用分析

Cost-utility analysis of the British Cardiovascular Interventional Society conveyance algorithm for patients with out-of-hospital cardiac arrest.
PubMed 文献 · Resuscitation · 2026-02-18
一句话结论基于观察性数据的模型分析显示,按英国心血管介入学会转运算法将初始可除颤心律患者直接转至心脏骤停中心,增量成本-效用比为每获得1个质量调整生命年2926英镑,在每质量调整生命年35000英镑支付阈值下具有成本效用的概率为86.0%。

本研究基于英国心血管介入学会的转运算法,构建决策树与马尔可夫混合决策分析模型,比较该算法与标准治疗在一生时间 horizon 内的成本-效用,模型输入来自一项当代观察性试点研究。结果显示算法具有成本效用,增量成本-效用比为每质量调整生命年2926英镑,重症监护、病房、评估后及救护车费用的降低部分被入院、神经预后评估和长期护理费用的轻度升高所抵消。概率分析显示在每质量调整生命年35000英镑支付阈值下成本效用概率为86.0%。作者认为尽管因观察性数据临床结局差异仍属探索性,该经济学评价支持进一步前瞻性多中心评估。

要点

  • 对初始可除颤心律的院外心脏骤停患者,英国心血管介入学会转运算法优先直接转至心脏骤停中心,以支持先进心脏干预、神经重症监护和结构化康复。
  • 与标准治疗相比,该算法增量成本-效用比为每质量调整生命年2926英镑,健康产出以质量调整生命年表示,医疗费用按年贴现率3.5%贴现。
  • 概率分析显示在每质量调整生命年35000英镑支付阈值下,该算法具有成本效用的概率为86.0%。
  • 重症监护、医院病房、评估后及救护车费用降低,部分被入院、神经预后评估和长期护理费用的轻度升高所抵消。
  • 作者认为因观察性数据临床结局差异仍属探索性,该经济学评价支持进一步前瞻性多中心评估以确认更广泛的临床和卫生系统获益。

适用人群与场景

  • 院外心脏骤停患者,初始心律为可除颤心律,适用英国心血管介入学会转运算法优先直接转至心脏骤停中心的人群。
  • 研究基于大型区域人群的区域性数据,比较该算法与标准治疗。

研究设计与关键结果

  • 研究类型为混合决策分析模型(决策树与马尔可夫模型结合),评估英国心血管介入学会转运算法对比标准治疗在一生时间 horizon 内的成本-效用,模型输入来自一项当代观察性试点研究。
  • 健康产出以质量调整生命年表示,医疗费用按年贴现率3.5%贴现,采用增量成本-效用比和净货币效益评估成本效用。
  • 转运算法具有成本效用,增量成本-效用比为每质量调整生命年2926英镑。
  • 重症监护、医院病房、评估后及救护车费用降低,部分被入院、神经预后评估和长期护理费用轻度升高所抵消。
  • 概率分析显示在每质量调整生命年35000英镑支付阈值下,成本效用概率为86.0%。

证据类型、等级与局限

  • 证据类型为基于观察性试点研究数据的决策分析模型(经济学评价),非随机对照试验。
  • 作者指出因观察性数据,临床结局差异仍属探索性。
  • 作者结论支持进一步前瞻性、多中心评估以确认更广泛的临床和卫生系统获益。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为选择性基于心律的转运至专科心脏骤停中心改善了资源效率且仅增加极低费用。
  • 作者认为该经济学评价支持进一步前瞻性多中心评估以确认更广泛的临床和卫生系统获益。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Out-of-hospital cardiac arrest is associated with high mortality and substantial healthcare costs. The British Cardiovascular Interventional Society's conveyance algorithm prioritises direct transfer of patients with an initial shockable rhythm to specialist Cardiac Arrest Centres to support access to advanced cardiac intervention, neurocritical care, and structured rehabilitation. This study evaluated the cost-effectiveness of implementing the conveyance algorithm in a large regional population.

METHODS: A hybrid decision-analytic model, combining a decision tree and Markov model was developed to assess the cost-effectiveness of the algorithm, compared with standard of care over a lifetime horizon. Model inputs were derived from a contemporary, observational pilot study. Health outcomes were expressed in quality-adjusted life years, and healthcare costs were discounted at an annual rate of 3.5%. Cost-effectiveness was assessed using the incremental cost-effectiveness ratio and net monetary benefit.

RESULTS: The conveyance algorithm was cost-effective, with an incremental cost-effectiveness ratio of £2926 per quality-adjusted life year gained. Reductions in intensive care, hospital ward, post-assessment, and ambulance costs were partially offset by slightly higher costs related to admission, neuroprognostication, and longer-term care. Probabilistic analysis showed an 86.0% probability of cost-effectiveness at a willingness-to-pay threshold of £35,000 per quality-adjusted life year.

CONCLUSION: Selective rhythm-based transfer to specialist cardiac arrest centres improved resource efficiency with minimal additional cost. Although clinical outcome differences remain exploratory due to observational data, this economic evaluation supports further prospective, multi-centre evaluation to confirm broader clinical and health system benefits.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Movio G, Sajjad U, Simpson R, et al. Cost-utility analysis of the British Cardiovascular Interventional Society conveyance algorithm for patients with out-of-hospital cardiac arrest. Resuscitation. 2026. PMID: 41720425. doi:10.1016/j.resuscitation.2026.111021

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。